PRMT5 and ovarian carcinoma: Given the important in ovarian cancer progression mediated by glycolysis flux, we applied previously designed and synthesized PRMT5 inhibitors, which block glycolysis flux, tumor growth, and enhance antitumor effects of Taxol in ovarian cancer.